Associate Professor of Medicine, Vanderbilt University
Infectious Disease
Dr. Stephen P. Raffanti, MD
|
|
Give Review
Doctor Stephen P. Raffanti, MD is an expert in the field of Infectious Disease. He has 2 awards "Nashville Lifestyles Magazine" and "Top MD". Stephen Raffanti is a published physician. He has 55 papers published. The most current publication "Acute non-lymphoblastic leukemia with an unusual chromosomal abnormality in a patient with advanced AIDS." Stephen Raffanti accepts all Medicare patients.
Publications
- CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy.
- Risk Prediction Tool for Medical Appointment Attendance Among HIV-Infected Persons with Unsuppressed Viremia.
- Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?
- Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators.
- Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.
- Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.
- Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors.
- Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures.
- Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
- Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral the...
- Improvements in access to care for HIV and AIDS in a statewide Medicaid managed care system.
- Rapidly progressing nodule in a patient with the acquired immunodeficiency syndrome. Primary cutaneous B-cell lymphoma.
- Determination of HIV-1 status of discarded sharps: polymerase chain reaction using minute quantities of blood.
- A long-term study of hepatitis B virus-related antigens and immunological parameters in children with chronic hepatitis.
- The role of HTLV in HIV-1 neurologic disease.
- Effect of a segregated-care system on patients' length of stay in intensive care.
- Impaired hepatic protein synthesis in AIDS patients with low vitamin A levels.
- Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II.
- Oral candidiasis as a marker of acute retroviral illness.
- Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-n...
- Two phases of HIV RNA decay in CSF during initial days of multidrug therapy.
- Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection.
- Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma.
- Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy.
- Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy.
- Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
- Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.
- Time's up.
- CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphoc...
- Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons.
- Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs.
- Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV.
- Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequenc...
- Psychosocial characteristics and sexual behaviors of people in care for HIV infection: an examination of men who have sex with men, heterosexual men and women.
- Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department ...
- Oxidant stress is increased during treatment of human immunodeficiency virus infection.
- Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment.
- Acute non-lymphoblastic leukemia with an unusual chromosomal abnormality in a patient with advanced AIDS.
- Randomized, double-blind, placebo-controlled trial of the immune modulator WF10 in patients with advanced AIDS.
- Association of ''(tropical) ataxic neuropathy'' with HTLV-II.
- Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses.
- Antiviral activity of coumermycin: identification of resistant and sensitive retrovirus strains.
- Characterization of tumor cell lines from a spontaneous rat sarcoma expressing an endogenous retrovirus.
- Assessment of cardiac function in patients with the acquired immunodeficiency syndrome.
- Native valve endocarditis due to Pseudallescheria boydii in a patient with AIDS: case report and review.
- AIDS: the widening circle.
- Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.
- Coumermycin inhibition of murine retrovirus replication in cultured cells.
- Sensitive micro in situ fluorescent focus assay for detection of murine xenotropic retroviruses.
- Host range differences among xenotropic type C retroviruses isolated from mouse kidney cell cultures.
- In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate.
- Effect of persistent moderate viremia on disease progression during HIV therapy.
- Fulminant Kaposi''s sarcoma without mucocutaneous disease.
- Misdiagnosis of HIV infection: implications for universal testing.
Schools
University of Genova Faculty of Medicine And Surgery
Raritan Bay Med Center
University Miami
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Nashville Lifestyles Magazine
- Top MD
Education
-
Jackson Memorial Hospital - Jackson Health System -
University of Genoa Faculty of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1285617332 | |
| NPPES Provider LastName | RAFFANTI | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 6985.0 | |
| Distinct Opioid Count | 11.0 | |
| Opioid Claim Count | 608.0 | |
| Percent Opioid Claims | 8.7 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285617332 |
| Last Name Of The Provider | RAFFANTI |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
|
Dr. Deborah L. Goldsmith, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd M. Hulgan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas Kernodle, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John Dummer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanette S. Ilarde, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ban Allos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Haas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carey K. Hwang, MD |
|
|
Dr. Ian Crozier, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. William Schaffner II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allen Kaiser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terence Dermody, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deidra D. Parrish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Helen K. Talbot, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul C. McNabb II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Spyros Kalams, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mark A. Pilkinton, MD
This Doctor is OpenDoctor Recommended.
|